A unit of Fresenius Kabi, a major supplier of infused and intravenously administered drugs, has agreed to plead guilty to hiding and destroying records before a 2013 plant inspection by the Food and Drug Administration, and will also pay $50 million in fines and forfeiture.

At issue is a plant operated in West Bengal, India, by Fresenius Kabi Oncology, which makes active pharmaceutical ingredients for various cancer medicines distributed in the U.S. According to the U.S. Department of Justice, plant managers directed employees to remove computers and documents, and delete other records that indicated proper manufacturing procedures were not being followed.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What’s included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.


Leave a Reply

ArabicChinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

[mc4wp_form id="449"]